The Fenofibrate Role In The Fight For Kidney Function Preservation

The Fenofibrate Role In The Fight For Kidney Function Preservation Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are increasingly significant global health concerns, with CKD now affecting an estimated 9.1% of the world's population—a 29.3% increase since 1990. This rise has severe implications, contributing to 1.2 million deaths annually

Sarcopenia And Chronic Kidney Disease

Sarcopenia And Chronic Kidney Disease Overview Sarcopenia and frailty are common conditions among people with chronic kidney disease (CKD), which may further enhance their risk of developing adverse health complications. Only a few studies have demonstrated the association between sarcopenia, frailty and chronic kidney disease in patients who are not on dialysis.

The Fenofibrate Role In The Fight For Kidney Function Preservation